TNFRSF17 and plasma cell myeloma: A clear separation of plasma/myeloma cells from BME immune cells was apparent from the enrichment of CD138+ cells (Supplementary Fig. 1g, h) and the high expression of the plasma cell marker TNFRSF17 encoding for BCMA.